BGIM
DOVA

Brandywine Global Investment Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Brandywine Global Investment Management’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-96,265
Closed -$2.69M – 902
2019
Q3 		$2.69M Sell
96,265
-22,086
-19% -$358K 0.02% 489
2019
Q2 		$1.67M Buy
118,351
+47,380
+67% +$451K 0.01% 553
2019
Q1 		$631K Buy
+70,971
New +$576K ﹤0.01% 559

Brandywine Global Investment Management's DOVA Position: Q4 2019 in Review

Brandywine Global Investment Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 96,265 shares — an estimated $2.69M sold.

Brandywine Global Investment Management first reported a position in DOVA in Q1 2019 and held it in 3 quarters. The position peaked at $2.69M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Brandywine Global Investment Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Brandywine Global Investment Management sold 96,265 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $2.69M.
  • Brandywine Global Investment Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Brandywine Global Investment Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $2.69M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Brandywine Global Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.